Latest Macular degeneration Stories
Research shows that, of 11 popular supplements analyzed, 7 do not adhere to proven formulas; all 11 have misleading claims SAN FRANCISCO, Dec.
TAU researchers develop groundbreaking wireless material capable of sparking neuronal activity in response to light.
Conference Call Scheduled for Wednesday, December 3rd to Provide Investor Update SAN DIEGO, Dec. 2, 2014 /PRNewswire/ -- Lpath, Inc.
an international team of researchers has found that under certain conditions, the retina can sense infrared light
LOUISVILLE, Ky., Dec.
Treatment of Visual Impairment due to Macular Edema Secondary to Central Retinal Vein Occlusion (CRVO) and Diabetic Macular Edema (DME) are the Second and Third Indications for Eylea(®) in Canada
TARRYTOWN, N.Y., Dec. 1, 2014 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S.
From dry eyes to glaucoma, brand stands out in the marketplace with special formulas Boca Raton, FL (PRWEB) November 24, 2014 Doctor’s Advantage Products,
National research foundation will host FREE seminars in Naples and Palm Beach Gardens on age-related macular degeneration to provide information on the latest research, treatment and technology for
CRESTWOOD, Ky., Nov. 20, 2014 /PRNewswire/ -- Apellis Pharmaceuticals announced today that it entered into an agreement to acquire Potentia Pharmaceuticals.
- To befool; deceive; balk; jilt.
- An illusion; a trick; a cheat.